You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

List of Excipients in API ozanimod hydrochloride

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing ozanimod hydrochloride

Subscribe to access the full database, or Get Started Free
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Celgene Corporation	ZEPOSIA	ozanimod hydrochloride	59572-820	CELLULOSE, MICROCRYSTALLINE	2033-03-24
Celgene Corporation	ZEPOSIA	ozanimod hydrochloride	59572-820	CROSCARMELLOSE SODIUM	2033-03-24
Celgene Corporation	ZEPOSIA	ozanimod hydrochloride	59572-820	MAGNESIUM STEARATE	2033-03-24
Celgene Corporation	ZEPOSIA	ozanimod hydrochloride	59572-820	SILICON DIOXIDE	2033-03-24
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for ozanimod hydrochloride

Excipient focus: CELLULOSE, MICROCRYSTALLINE

ozanimod hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Celgene Corporation	ozanimod hydrochloride	59572-820
>Company	>Ingredient	>NDC

ozanimod hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSCARMELLOSE SODIUM

ozanimod hydrochloride drug variants containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Celgene Corporation	ozanimod hydrochloride	59572-820
>Company	>Ingredient	>NDC

ozanimod hydrochloride drug variants not containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

ozanimod hydrochloride drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Celgene Corporation	ozanimod hydrochloride	59572-820
>Company	>Ingredient	>NDC

ozanimod hydrochloride drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SILICON DIOXIDE

ozanimod hydrochloride drug variants containing SILICON DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Celgene Corporation	ozanimod hydrochloride	59572-820
>Company	>Ingredient	>NDC

ozanimod hydrochloride drug variants not containing SILICON DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.